Many of the cardiovascular and metabolic trials informing the discussion were not designed to evaluate ophthalmic outcomes. The authors called for prospective ophthalmology-specific studies incorporating imaging biomarkers, visual outcomes and disease-specific monitoring, noting that parsing the protective benefits or adverse effects of this rapidly growing medication class will be essential to refining disease management and improve patient outcomes. As GLP-1 therapies become increasingly common among patients with diabetes, obesity and vascular comorbiditiesprecisely the populations populating ophthalmic clinicsthe field may not have the luxury of waiting for cleaner data
Concentrate more on your exercise repetitions to reap the best results
SA--gal-positive cells (blue color) were counted under microscope (BX51, Olympus, Japan)
The deltoid muscle, which gives your shoulder its rounded shape, is incredibly easy to access
Get guidance, accountability, and encouragement to help you stay on track
The researchers reached similar conclusions whether they examined people after about one year of GLP-1 use or over a longer, two-year period